Commitment to Patients - Sustainability | Takeda Pharmaceuticals
Our Commitment to Patients
Translating science to discover and deliver life-transforming treatments and vaccines for patients and communities with limited or no options is central to our purpose. We deliver our pipeline through expert R&D capabilities within our laboratories and extensive external R&D partnerships, collaboration with patient communities, addressing health equity and leveraging data, digital and technology capabilities.
We’re accelerating access to innovative healthcare for more people worldwide.
Key objectives
We focus on the highest unmet need, both in rare and more prevalent conditions, to deliver high-quality medicines and vaccines to patients as quickly as possible.
Measurable priorities
Priority 1
Deliver life-transforming medicines and vaccines to people by cultivating the best science generated through our strong internal research and development capabilities complemented by our extensive partnership network.
Priority 2
Embed a patient-centric and science-driven approach from discovery through commercialization to ensure rapid, global access to all transformative medicines and vaccines.
Priority 3
Ensure the high-quality, uninterrupted supply and delivery of our medicines and vaccines to people by harnessing innovation.
We partner with diverse stakeholders to support the sustainability of health care systems.
Measurable priorities
Priority 1
Provide timely, broad and sustainable access to our innovative medicines worldwide.
Priority 2
Ensure sustainable access to our innovative medicines for patients diagnosed with a serious condition in underserved communities, in particular where there are no medical alternatives.
Priority 3
Improve patient outcomes and create societal value through partnerships.